Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Defense
- Branch
- Office for Chemical and Biological Defense
- Recipient company
- TPL, INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- ZC4PPSM47QQ3
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
U.S. forces require rapid, early and accurate pathogen detection systems designed for use in extreme combat situations. Numerous options to deliver weaponized pathogens drives the necessity for U.S. forces to have technology to detect infectious pathogens.TPL has conceived a unique methodology for amplifying the presence of a pathogen without multiplying physical number of pathogens. TPL proposes using our highly stabilized acoustic wave sensor system that significantly reduces or eliminates inherentsusceptibility to various interferents (temperature, shock, internally and externally generated spurious noise, etc) to detect the biomolecular amplification cascade. Combined, these two innovations address the most critical issues in pathogen detection.In Phase I, TPL will demonstrate the feasibility of these two critical elements in a biosensor instrumentation system. The biomolecular amplification technique will be verified. The ability of the biosensor to detect the amplification agents will beconfirmed.The P.I. is responsible for the development of the highly stabilized acoustic wave sensor overcoming environmental sensitivities, which have plagued similar sensor developments. TPL will continue its collaborative relationship with the staff at theUniversity of New Mexico's Health Science Center in the use of this sensor for biochemistry-related measurements. The major commercial application of the proposed amplification of molecular signal using highly stabilized acoustic wave sensor will be inthe rapid, early and accurate infectious pathogen. Safeguarding all urban office and commercial facilities of high priority in the United States. These types of pathogen detection systems could be used in a mobile hand held units or could be used as fixedinstallations where large groups of people pass through. The number of this type of sensor system that could be sold to government and private companies could conceivably be in the hundreds of thousands.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
220 SBIR/STTR records share this UEI (1984–2022). Reported award amounts total $49,867,963. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, Department of Energy, National Science Foundation, National Aeronautics and Space Administration, Department of Health and Human Services, Nuclear Regulatory Commission
Agency intelligence
Department of Defense
Back to SBIR/STTR Research Awards